HOME >> BIOLOGY >> NEWS
Unusual antibiotics show promise against deadly 'superbugs'

WASHINGTON, Aug. 29 An unusual type of antibiotic being developed by chemists at University of Notre Dame shows promise in defeating deadly "superbugs" highly drug-resistant staph bacteria that are an increasing source of hospital-based infections. The novel antibiotics, which could some day save lives, were described today at the 230th national meeting of the American Chemical Society, the worlds largest scientific society.

The new antibiotics are synthetic forms of cephalosporin, a broad-spectrum antibiotic closely related to penicillin. They appear to kill bacteria by masquerading as components of the bacterial cell wall in order to deactivate an enzyme that functions as a key bacterial defense mechanism, the researchers say. In preliminary lab tests, the new antibiotics the first to exhibit this mimicry mechanism were effective against vancomycin-resistant MRSA, a rare but extremely deadly staph strain for which treatment options are extremely limited, they say.

"We are the first to demonstrate this unique strategy, which could provide a new line of defense against the growing problem of antibiotic resistance," says study leader Shahriar Mobashery, Ph.D., a chemist at the university. "As scientists, were trying to stay one step ahead of the bacteria. The more strategies there are to fight resistance, the better."

Besides fighting staph bacteria, the compounds have the potential to work against a wide range of other types of infectious bacterial strains that appear in health-care and community settings, he says. At least one of the cephalosporin compounds identified has entered Phase I clinical trials (human studies), but results are not yet available. More studies are needed before it can be marketed, Mobashery and his associates say.

MRSA (methicillin-resistant Staphylococcus aureus) was first identified in the early 1960s and has become a difficult superbug to tame. While searching for strategies to defeat it, Mobasher
'"/>


29-Aug-2005


Page: 1 2 3

Related biology news :

1. Unusual three-drug combo inhibits growth of aggressive tumors
2. Unusual data shed new light on brain and inhibiting behavior
3. Unusual mechanism keeps repair protein accurate
4. Unusual RNAs linked to chronic leukemia, may help treat it
5. Unusual reproductive behavior of odd ants surprises scientists
6. Researchers watch antibiotics, bacteria meet at atomic level
7. UBC researchers find new superbug weapon for near-empty antibiotics arsenal
8. Will the plague pathogen become resistant to antibiotics?
9. Natural antibiotics yield secrets to atom-level imaging technique
10. Compounds in cranberry juice show promise as alternatives to antibiotics
11. Protein clue to tailor-made antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... June 18, 2020 , ... ... series, “Automate Your Lab with Software for Data Decisions,” for pharmaceutical and ... how to integrate and automate cutting-edge scientific instruments and laboratory equipment from ...
(Date:6/5/2020)... ... ... Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq ... Next Generation Genomic Sequencing (NGS) . This is the third application filed by SimplSeq ... “I have been at the bench for over 20 years,” stated Brandon Young, CTO ...
(Date:5/28/2020)... ... ... CrucialTrak, a global designer and manufacturer of biometric access control systems, today announced that ... its complete line of biometric readers and access gates . CEG is a ... , Brett Mason, CrucialTrak’s Director of Channel Sales for the Americas is very excited ...
Breaking Biology News(10 mins):
(Date:6/2/2020)... SPRINGFIELD, Ill. (PRWEB) , ... June 01, 2020 ... ... a helping hand to companies and encourage positive change in the world, enterprise ... the coronavirus pandemic. , With more people working from home during self-quarantines and ...
(Date:5/28/2020)... ... May 28, 2020 , ... Genedata, the leading ... Genedata Screener ® 17.0, the latest version of its enterprise software for ... assay technologies. Genedata will host a webinar on June 10, 2020, detailing and ...
(Date:5/21/2020)... ... May 21, 2020 , ... Threats to intellectual property, political ... Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical ... from the pandemic commercially weaker, dealing with delays in new product launches and ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... Simon Prakash, who will serve as the company’s executive vice president of product ... when Exo is disrupting the medical imaging space, bringing more than 24 years ...
Breaking Biology Technology:
Cached News: